News about JelliSee Ophthalmics
Julie Schallhorn, MD Appointed Chief Medical Advisor at JelliSee Ophthalmics
McLean, VA – August 28, 2025 – JelliSee Ophthalmics Inc. today announced the appointment of Julie Schallhorn, MD as Chief Medical Advisor. In this expanded role, Dr. Schallhorn will provide strategic clinical oversight as the company advances its programs both outside the United States (OUS) and, ultimately, into U.S. clinical trials.
Dr. Schallhorn is internationally recognized for her expertise in intraocular lens (IOL) technology, as well as cataract and refractive surgery.
“We are thrilled Dr. Schallhorn has accepted this new role,” said Jim Ellis, MD, founder and CEO of JelliSee Ophthalmics Inc. “Her deep knowledge in optics, advanced-technology IOLs, clinical study design, and outcomes measurement adds significant strength to our team as we begin our next OUS studies and prepare for future FDA submissions.”
“I am super excited to be working with this amazing technology,” said Dr. Schallhorn. “I truly believe it is a transformative advancement in vision restoration for patients.”
Dr. Schallhorn is internationally recognized for her expertise in intraocular lens (IOL) technology, as well as cataract and refractive surgery.
“We are thrilled Dr. Schallhorn has accepted this new role,” said Jim Ellis, MD, founder and CEO of JelliSee Ophthalmics Inc. “Her deep knowledge in optics, advanced-technology IOLs, clinical study design, and outcomes measurement adds significant strength to our team as we begin our next OUS studies and prepare for future FDA submissions.”
“I am super excited to be working with this amazing technology,” said Dr. Schallhorn. “I truly believe it is a transformative advancement in vision restoration for patients.”
About JelliSee Ophthalmics
JelliSee Ophthalmics Inc. is developing a truly accommodating intraocular lens designed to restore the eye’s natural focusing ability, delivering clear vision across all distances without the trade-offs associated with current presbyopia-correcting IOLs. For more information, visit www.jellisee.com.
JelliSee Ophthalmics Inc. is developing a truly accommodating intraocular lens designed to restore the eye’s natural focusing ability, delivering clear vision across all distances without the trade-offs associated with current presbyopia-correcting IOLs. For more information, visit www.jellisee.com.
JelliSee Ophthalmics selected to present as a featured company at the
Philadelphia Alliance for Capital and Technologies (PACT)
Mid-Atlantic Capital Conference on November 8-9, 2023
philadelphiapact.com/2023-capital-conference/
Philadelphia Alliance for Capital and Technologies (PACT)
Mid-Atlantic Capital Conference on November 8-9, 2023
philadelphiapact.com/2023-capital-conference/
Jim Ellis MD, CEO of JelliSee Ophthalmics, presents
"Accommodating IOLs: Biomechanical Considerations"
at May 2023 ASCRS Annual Meeting
https://subspecialtyday.ascrs.org/home/clinical-education/presbyopia/2023/2023-ms-6-5-ellis-accommodating-iols-biomechanical-considerations
"Accommodating IOLs: Biomechanical Considerations"
at May 2023 ASCRS Annual Meeting
https://subspecialtyday.ascrs.org/home/clinical-education/presbyopia/2023/2023-ms-6-5-ellis-accommodating-iols-biomechanical-considerations
JelliSee Ophthalmics Wins 1st Prize
at the 2021 ASCRS Winning Pitch Challenge!
The finals for the Winning Pitch Challenge were held at ASCRS 2021 in Las Vegas, NV on Monday, July 26, 2021.
Our Founder and CEO Jim Ellis, MD, presented the JelliSee Accommodating IOL and the company won 1st Prize in the competition!
See the short video that follows which presents the finalists and honorable mentions
at the 2021 ASCRS Winning Pitch Challenge!
The finals for the Winning Pitch Challenge were held at ASCRS 2021 in Las Vegas, NV on Monday, July 26, 2021.
Our Founder and CEO Jim Ellis, MD, presented the JelliSee Accommodating IOL and the company won 1st Prize in the competition!
See the short video that follows which presents the finalists and honorable mentions
